Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
1.24
-0.03 (-2.36%)
At close: Jun 13, 2025, 3:59 PM
1.25
0.76%
After-hours: Jun 13, 2025, 05:24 PM EDT
-2.36% (1D)
| Bid | 1.23 |
| Market Cap | 228.14M |
| Revenue (ttm) | 396.59K |
| Net Income (ttm) | -35.36M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -4.59 |
| Forward PE | -5.56 |
| Analyst | Buy |
| Ask | 1.25 |
| Volume | 533,880 |
| Avg. Volume (20D) | 952,206 |
| Open | 1.23 |
| Previous Close | 1.27 |
| Day's Range | 1.23 - 1.26 |
| 52-Week Range | 0.26 - 3.09 |
| Beta | -0.67 |
About TVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+7.74%
Tevogen Bio Holdings shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
-5.52%
Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.
